Related Experiment Video
Updated: Aug 9, 2026
08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Ovarian dysgerminoma: a therapeutic challenge
1Department of Radiotherapy, Institut Jules Bordet, Brussels, Belgium.
Journal Belge De Radiologie
|March 1, 1993
Summary
Dysgerminoma survival rates have significantly improved, now exceeding 80% due to advances in diagnosis and treatment. The focus is on curing patients while preserving ovarian function and fertility.
Area of Science:
- Gynecologic Oncology
- Reproductive Endocrinology
Background:
- Dysgerminoma is a rare ovarian germ cell tumor.
- Historically, prognosis was poor, with 5-year survival around 30%.
Purpose of the Study:
- To highlight the improved prognosis of dysgerminoma.
- To emphasize the importance of precise diagnosis and staging.
- To underscore the goal of preserving quality of life, including ovarian function and fertility.
Main Methods:
- Review of historical and current survival data for dysgerminoma.
- Analysis of diagnostic and staging advancements.
- Evaluation of treatment strategies focused on fertility preservation.
Main Results:
- 5-year survival for dysgerminoma has increased from approximately 30% to over 80% in the last 40 years.
- Accurate diagnosis and staging are crucial for effective treatment planning.
Conclusions:
- Modern management has dramatically improved dysgerminoma outcomes.
- Treatment aims for cure while prioritizing ovarian function and fertility preservation.
